Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:quinuclidinyl benzilate'
(id=6730940 ; fe=en:quinuclidinyl benzilate ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1120 creation date=2017-06-21 touchdate=2025-06-19 20:17:47.000)
≈ 39 relations sortantes

  1. en:quinuclidinyl benzilate -- r_associated #0: 39 / 1 -> en:agonists
    n1=en:quinuclidinyl benzilate | n2=en:agonists | rel=r_associated | relid=0 | w=39
  2. en:quinuclidinyl benzilate -- r_associated #0: 37 / 0.949 -> en:mechanism of action qualifier
    n1=en:quinuclidinyl benzilate | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=37
  3. en:quinuclidinyl benzilate -- r_associated #0: 36 / 0.923 -> en:therapeutic use - qualifier
    n1=en:quinuclidinyl benzilate | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=36
  4. en:quinuclidinyl benzilate -- r_associated #0: 35 / 0.897 -> en:chemical synthesis
    n1=en:quinuclidinyl benzilate | n2=en:chemical synthesis | rel=r_associated | relid=0 | w=35
  5. en:quinuclidinyl benzilate -- r_associated #0: 35 / 0.897 -> en:mequitazine
    n1=en:quinuclidinyl benzilate | n2=en:mequitazine | rel=r_associated | relid=0 | w=35
  6. en:quinuclidinyl benzilate -- r_associated #0: 35 / 0.897 -> en:toxicity aspects
    n1=en:quinuclidinyl benzilate | n2=en:toxicity aspects | rel=r_associated | relid=0 | w=35
  7. en:quinuclidinyl benzilate -- r_associated #0: 34 / 0.872 -> en:1-benzilic-4,4'-quinuclidinyl benzilate
    n1=en:quinuclidinyl benzilate | n2=en:1-benzilic-4,4'-quinuclidinyl benzilate | rel=r_associated | relid=0 | w=34
  8. en:quinuclidinyl benzilate -- r_associated #0: 34 / 0.872 -> en:quinine
    n1=en:quinuclidinyl benzilate | n2=en:quinine | rel=r_associated | relid=0 | w=34
  9. en:quinuclidinyl benzilate -- r_associated #0: 32 / 0.821 -> en:historical aspects qualifier
    n1=en:quinuclidinyl benzilate | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=32
  10. en:quinuclidinyl benzilate -- r_associated #0: 32 / 0.821 -> en:in urine
    n1=en:quinuclidinyl benzilate | n2=en:in urine | rel=r_associated | relid=0 | w=32
  11. en:quinuclidinyl benzilate -- r_associated #0: 32 / 0.821 -> en:metabolic aspects
    n1=en:quinuclidinyl benzilate | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=32
  12. en:quinuclidinyl benzilate -- r_associated #0: 32 / 0.821 -> en:quinidine
    n1=en:quinuclidinyl benzilate | n2=en:quinidine | rel=r_associated | relid=0 | w=32
  13. en:quinuclidinyl benzilate -- r_associated #0: 32 / 0.821 -> en:quinuclidinyl-2-thienyl-4-bromobenzilate
    n1=en:quinuclidinyl benzilate | n2=en:quinuclidinyl-2-thienyl-4-bromobenzilate | rel=r_associated | relid=0 | w=32
  14. en:quinuclidinyl benzilate -- r_associated #0: 32 / 0.821 -> en:solifenacin
    n1=en:quinuclidinyl benzilate | n2=en:solifenacin | rel=r_associated | relid=0 | w=32
  15. en:quinuclidinyl benzilate -- r_associated #0: 32 / 0.821 -> en:solifenacin succinate
    n1=en:quinuclidinyl benzilate | n2=en:solifenacin succinate | rel=r_associated | relid=0 | w=32
  16. en:quinuclidinyl benzilate -- r_associated #0: 31 / 0.795 -> en:benzilates
    n1=en:quinuclidinyl benzilate | n2=en:benzilates | rel=r_associated | relid=0 | w=31
  17. en:quinuclidinyl benzilate -- r_associated #0: 31 / 0.795 -> en:exposure as collected domain
    n1=en:quinuclidinyl benzilate | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=31
  18. en:quinuclidinyl benzilate -- r_associated #0: 31 / 0.795 -> en:pharmacokinetic aspects
    n1=en:quinuclidinyl benzilate | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=31
  19. en:quinuclidinyl benzilate -- r_associated #0: 30 / 0.769 -> en:chemical aspects
    n1=en:quinuclidinyl benzilate | n2=en:chemical aspects | rel=r_associated | relid=0 | w=30
  20. en:quinuclidinyl benzilate -- r_associated #0: 30 / 0.769 -> en:clidinium compounds
    n1=en:quinuclidinyl benzilate | n2=en:clidinium compounds | rel=r_associated | relid=0 | w=30
  21. en:quinuclidinyl benzilate -- r_associated #0: 30 / 0.769 -> en:contraindications aspect
    n1=en:quinuclidinyl benzilate | n2=en:contraindications aspect | rel=r_associated | relid=0 | w=30
  22. en:quinuclidinyl benzilate -- r_associated #0: 30 / 0.769 -> en:technetium tc 99m cl(dmg)3b-qnb
    n1=en:quinuclidinyl benzilate | n2=en:technetium tc 99m cl(dmg)3b-qnb | rel=r_associated | relid=0 | w=30
  23. en:quinuclidinyl benzilate -- r_associated #0: 29 / 0.744 -> en:aspects of radiation effects
    n1=en:quinuclidinyl benzilate | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=29
  24. en:quinuclidinyl benzilate -- r_associated #0: 29 / 0.744 -> en:clidinium
    n1=en:quinuclidinyl benzilate | n2=en:clidinium | rel=r_associated | relid=0 | w=29
  25. en:quinuclidinyl benzilate -- r_associated #0: 29 / 0.744 -> en:in blood
    n1=en:quinuclidinyl benzilate | n2=en:in blood | rel=r_associated | relid=0 | w=29
  26. en:quinuclidinyl benzilate -- r_associated #0: 29 / 0.744 -> en:quinuclidines
    n1=en:quinuclidinyl benzilate | n2=en:quinuclidines | rel=r_associated | relid=0 | w=29
  27. en:quinuclidinyl benzilate -- r_associated #0: 29 / 0.744 -> en:taxonomic
    n1=en:quinuclidinyl benzilate | n2=en:taxonomic | rel=r_associated | relid=0 | w=29
  28. en:quinuclidinyl benzilate -- r_associated #0: 28 / 0.718 -> en:parasympatholytics
    n1=en:quinuclidinyl benzilate | n2=en:parasympatholytics | rel=r_associated | relid=0 | w=28
  29. en:quinuclidinyl benzilate -- r_associated #0: 27 / 0.692 -> en:3-quinuclidinyl 4-azidobenzilate
    n1=en:quinuclidinyl benzilate | n2=en:3-quinuclidinyl 4-azidobenzilate | rel=r_associated | relid=0 | w=27
  30. en:quinuclidinyl benzilate -- r_associated #0: 27 / 0.692 -> en:3-quinuclidinyl-4-iodobenzilate
    n1=en:quinuclidinyl benzilate | n2=en:3-quinuclidinyl-4-iodobenzilate | rel=r_associated | relid=0 | w=27
  31. en:quinuclidinyl benzilate -- r_associated #0: 27 / 0.692 -> en:analysis aspect
    n1=en:quinuclidinyl benzilate | n2=en:analysis aspect | rel=r_associated | relid=0 | w=27
  32. en:quinuclidinyl benzilate -- r_associated #0: 27 / 0.692 -> en:in cerebrospinal fluid
    n1=en:quinuclidinyl benzilate | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=27
  33. en:quinuclidinyl benzilate -- r_associated #0: 26 / 0.667 -> en:aspects of adverse effects
    n1=en:quinuclidinyl benzilate | n2=en:aspects of adverse effects | rel=r_associated | relid=0 | w=26
  34. en:quinuclidinyl benzilate -- r_associated #0: 26 / 0.667 -> en:benactyzine
    n1=en:quinuclidinyl benzilate | n2=en:benactyzine | rel=r_associated | relid=0 | w=26
  35. en:quinuclidinyl benzilate -- r_associated #0: 26 / 0.667 -> en:immunology aspects
    n1=en:quinuclidinyl benzilate | n2=en:immunology aspects | rel=r_associated | relid=0 | w=26
  36. en:quinuclidinyl benzilate -- r_associated #0: 26 / 0.667 -> en:poisoning aspects
    n1=en:quinuclidinyl benzilate | n2=en:poisoning aspects | rel=r_associated | relid=0 | w=26
  37. en:quinuclidinyl benzilate -- r_associated #0: 26 / 0.667 -> en:standards characteristics
    n1=en:quinuclidinyl benzilate | n2=en:standards characteristics | rel=r_associated | relid=0 | w=26
  38. en:quinuclidinyl benzilate -- r_associated #0: 20 / 0.513 -> benzilates
    n1=en:quinuclidinyl benzilate | n2=benzilates | rel=r_associated | relid=0 | w=20
  39. en:quinuclidinyl benzilate -- r_associated #0: 2 / 0.051 -> en:indicator, reagent, or diagnostic aid
    n1=en:quinuclidinyl benzilate | n2=en:indicator, reagent, or diagnostic aid | rel=r_associated | relid=0 | w=2
≈ 41 relations entrantes

  1. benzilates --- r_associated #0: 70 --> en:quinuclidinyl benzilate
    n1=benzilates | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=70
  2. en:benzilates --- r_associated #0: 66 --> en:quinuclidinyl benzilate
    n1=en:benzilates | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=66
  3. en:agonists --- r_associated #0: 35 --> en:quinuclidinyl benzilate
    n1=en:agonists | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=35
  4. en:clidinium compounds --- r_associated #0: 35 --> en:quinuclidinyl benzilate
    n1=en:clidinium compounds | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=35
  5. en:quinuclidinyl-2-thienyl-4-bromobenzilate --- r_associated #0: 34 --> en:quinuclidinyl benzilate
    n1=en:quinuclidinyl-2-thienyl-4-bromobenzilate | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=34
  6. en:therapeutic use - qualifier --- r_associated #0: 34 --> en:quinuclidinyl benzilate
    n1=en:therapeutic use - qualifier | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=34
  7. en:parasympatholytics --- r_associated #0: 31 --> en:quinuclidinyl benzilate
    n1=en:parasympatholytics | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=31
  8. en:1-benzilic-4,4'-quinuclidinyl benzilate --- r_associated #0: 30 --> en:quinuclidinyl benzilate
    n1=en:1-benzilic-4,4'-quinuclidinyl benzilate | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=30
  9. en:analysis aspect --- r_associated #0: 30 --> en:quinuclidinyl benzilate
    n1=en:analysis aspect | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=30
  10. en:benactyzine --- r_associated #0: 30 --> en:quinuclidinyl benzilate
    n1=en:benactyzine | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=30
  11. en:mechanism of action qualifier --- r_associated #0: 30 --> en:quinuclidinyl benzilate
    n1=en:mechanism of action qualifier | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=30
  12. en:chemical aspects --- r_associated #0: 29 --> en:quinuclidinyl benzilate
    n1=en:chemical aspects | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=29
  13. en:clidinium --- r_associated #0: 29 --> en:quinuclidinyl benzilate
    n1=en:clidinium | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=29
  14. en:contraindications aspect --- r_associated #0: 29 --> en:quinuclidinyl benzilate
    n1=en:contraindications aspect | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=29
  15. en:in urine --- r_associated #0: 29 --> en:quinuclidinyl benzilate
    n1=en:in urine | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=29
  16. en:standards characteristics --- r_associated #0: 29 --> en:quinuclidinyl benzilate
    n1=en:standards characteristics | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=29
  17. en:3-quinuclidinyl 4-azidobenzilate --- r_associated #0: 28 --> en:quinuclidinyl benzilate
    n1=en:3-quinuclidinyl 4-azidobenzilate | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=28
  18. en:mequitazine --- r_associated #0: 28 --> en:quinuclidinyl benzilate
    n1=en:mequitazine | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=28
  19. en:quinuclidines --- r_associated #0: 28 --> en:quinuclidinyl benzilate
    n1=en:quinuclidines | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=28
  20. en:solifenacin succinate --- r_associated #0: 27 --> en:quinuclidinyl benzilate
    n1=en:solifenacin succinate | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=27
  21. en:taxonomic --- r_associated #0: 27 --> en:quinuclidinyl benzilate
    n1=en:taxonomic | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=27
  22. en:technetium tc 99m cl(dmg)3b-qnb --- r_associated #0: 27 --> en:quinuclidinyl benzilate
    n1=en:technetium tc 99m cl(dmg)3b-qnb | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=27
  23. en:3-quinuclidinyl-4-iodobenzilate --- r_associated #0: 26 --> en:quinuclidinyl benzilate
    n1=en:3-quinuclidinyl-4-iodobenzilate | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=26
  24. en:pharmacokinetic aspects --- r_associated #0: 26 --> en:quinuclidinyl benzilate
    n1=en:pharmacokinetic aspects | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=26
  25. en:quinidine --- r_associated #0: 25 --> en:quinuclidinyl benzilate
    n1=en:quinidine | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=25
  26. en:in blood --- r_associated #0: 24 --> en:quinuclidinyl benzilate
    n1=en:in blood | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=24
  27. en:toxicity aspects --- r_associated #0: 24 --> en:quinuclidinyl benzilate
    n1=en:toxicity aspects | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=24
  28. en:aspects of adverse effects --- r_associated #0: 23 --> en:quinuclidinyl benzilate
    n1=en:aspects of adverse effects | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=23
  29. en:historical aspects qualifier --- r_associated #0: 23 --> en:quinuclidinyl benzilate
    n1=en:historical aspects qualifier | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=23
  30. en:quinine --- r_associated #0: 22 --> en:quinuclidinyl benzilate
    n1=en:quinine | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=22
  31. en:aspects of radiation effects --- r_associated #0: 20 --> en:quinuclidinyl benzilate
    n1=en:aspects of radiation effects | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=20
  32. en:chemical synthesis --- r_associated #0: 20 --> en:quinuclidinyl benzilate
    n1=en:chemical synthesis | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=20
  33. en:exposure as collected domain --- r_associated #0: 20 --> en:quinuclidinyl benzilate
    n1=en:exposure as collected domain | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=20
  34. en:immunology aspects --- r_associated #0: 20 --> en:quinuclidinyl benzilate
    n1=en:immunology aspects | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=20
  35. en:in cerebrospinal fluid --- r_associated #0: 20 --> en:quinuclidinyl benzilate
    n1=en:in cerebrospinal fluid | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=20
  36. en:metabolic aspects --- r_associated #0: 20 --> en:quinuclidinyl benzilate
    n1=en:metabolic aspects | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=20
  37. en:poisoning aspects --- r_associated #0: 20 --> en:quinuclidinyl benzilate
    n1=en:poisoning aspects | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=20
  38. en:solifenacin --- r_associated #0: 20 --> en:quinuclidinyl benzilate
    n1=en:solifenacin | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=20
  39. quinidine --- r_associated #0: 10 --> en:quinuclidinyl benzilate
    n1=quinidine | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=10
  40. quinine --- r_associated #0: 10 --> en:quinuclidinyl benzilate
    n1=quinine | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=10
  41. taxinomique --- r_associated #0: 10 --> en:quinuclidinyl benzilate
    n1=taxinomique | n2=en:quinuclidinyl benzilate | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr